NovaBridge Biosciences
NBP | NASDAQ
$0.79
-$0.06 (-7.05%)
At close: Nov 16, 2026, 4:00 PM ET
$0.79
$0.00 (0.00%)
Pre-market:
Nov 17, 2026, 4:00 AM ET
NovaBridge Biosciences Cash Flow Statement
Cash flow statement explainedTTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -159.32M | -153.72M | -157.67M | -150.96M | -246.08M | -52.74M | -9.03M | -289.33M | -491.98M | -1.06B | -1.47B | -3.63B | -4.01B | -3.7B | -3.84B | -1.96B | -1.86B | -2.32B | -2.33B | -662.46M | -22.71M | 224.1M | |
| 4.75M | 2.55M | 1.77M | 3.09M | 2.94M | 3.74M | 4.6M | 3.9M | 2.87M | 337.96M | 672.99M | 684.29M | 690.01M | 360.22M | 30.44M | 27.25M | 30.1M | 30.97M | 31.84M | 24.28M | 16.19M | 13.8M | |
| 21.1M | 19.86M | 18.64M | 26.02M | 17.75M | 23.87M | 7.97M | 25.74M | 52.73M | 111.88M | 193M | 244.01M | 295.02M | 242.31M | 273.37M | 330.21M | 387.05M | 539.72M | 608.61M | 572.55M | 598.39M | 545.93M | |
| 64.66M | 67.54M | 70.43M | 60.15M | – | – | – | – | – | – | – | 174.84M | 174.84M | 176.19M | 185.2M | 10.61M | 34.34M | 76.38M | 110.76M | 9.46M | -17.88M | -65.93M | |
| 44.77M | 56.12M | 75.64M | 85.1M | 225.38M | 25.13M | -3.54M | 259.69M | 436.38M | 608.62M | 599.7M | 344.11M | 671.16M | 699.73M | 829.63M | -974.1M | -1.39B | -1.36B | -1.43B | 415.6M | -217.76M | -257.75M | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 54.41M | 57.29M | 60.17M | 49.9M | – | – | – | – | – | – | – | 235.16M | 235.16M | 238.18M | 258.45M | 258.45M | 246.58M | 344.44M | 425.06M | -41.65M | -33.4M | -138.94M | |
| -34.3M | -17.9M | -1.45M | 13.15M | – | – | – | – | – | – | – | -2.12B | -2.12B | -2.16B | -2.45B | -2.32B | -2.58B | -2.76B | -2.7B | 308.32M | 340.71M | 387.13M | |
| -987.83K | -494.58K | 41 | 41 | – | – | – | – | – | – | – | -37.96M | -37.96M | -39.37M | -48.8M | -12.88M | -25.81M | -26.43M | -19.03M | -20.24M | -11.93M | -9.97M | |
| -161 | -161 | -161 | -161 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 171.53K | 171.53K | 171.53K | 171.53K | – | – | – | – | – | – | – | -5.15B | -5.15B | -5.15B | -5.15B | -7.92B | -7.92B | -7.92B | -7.92B | -2.22B | -2.38B | -2.38B | |
| -531.77K | -531.77K | -531.77K | -531.77K | – | – | – | – | – | – | – | 5.68B | 5.68B | 5.68B | 5.68B | 7.26B | 7.26B | 7.26B | 7.26B | 2.23B | 2.36B | 2.36B | |
| 13.2M | 6.61M | – | – | – | – | – | – | – | – | – | -91.46M | -91.46M | -52.8M | 206.31M | 200.28M | 40.31M | -187.01M | -634.78M | -485.3M | -582.97M | -379.07M | |
| 11.86M | 5.76M | -360.38K | -360.38K | – | – | – | – | – | – | – | 403.9M | 403.9M | 441.15M | 690.82M | -494.76M | -667.68M | -895.62M | -1.34B | -499.81M | -613.64M | -407.77M | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -328.7K | -602.01K | -602.01K | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -229.16K | -5.34M | -5.34M | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -70.89M | -71.26M | -71.63M | -6.89M | – | – | – | – | – | – | – | -2.79B | -2.79B | -2.78B | -2.77B | -2.77B | -2.71B | -2.47B | -2.25B | 1.24B | 2.84B | 2.92B | |
| 431.1M | 430.73M | 430.36M | 433.38M | – | – | – | – | – | – | – | -2.79B | -2.79B | -2.78B | -2.77B | -2.77B | -2.71B | -2.47B | -2.25B | 1.38B | 3.27B | 3.36B | |
| 215.31M | 215.31M | 428.69M | 446.12M | – | – | – | – | – | – | – | -4.39B | -4.39B | -4.37B | -4.28B | -5.33B | -5.75B | -5.96B | -6.26B | 976.83M | 2.79B | 3.18B | |
| -35.29M | -18.39M | -1.45M | 13.15M | – | – | – | – | – | – | – | -2.16B | -2.16B | -2.2B | -2.5B | -2.33B | -2.61B | -2.79B | -2.72B | 288.08M | 328.78M | 377.16M | |
| -56.39M | -38.26M | -20.09M | -12.87M | -17.75M | -23.87M | -7.97M | -25.74M | -52.73M | -111.88M | -193M | -2.4B | -2.45B | -2.44B | -2.77B | -2.66B | -3B | -3.33B | -3.32B | -284.48M | -269.62M | -168.77M | |
| -987.83K | -494.58K | 41 | 41 | – | – | – | – | – | – | – | – | – | – | -6.6M | -8.63M | -18.95M | -20.15M | -14.75M | -12.72M | -7.02M | -5.89M | |
| – | – | – | – | – | – | – | – | – | – | – | -37.96M | -37.96M | -39.37M | -42.2M | -4.25M | -6.86M | -6.28M | -4.28M | -7.53M | -4.91M | -4.08M | |
| -35.29M | -18.4M | -1.45M | 13.15M | – | – | – | – | – | – | – | -2.12B | -2.12B | -2.16B | -2.45B | -2.33B | -2.6B | -2.78B | -2.71B | 295.6M | 333.69M | 381.24M |
Add to Watchlist
Select watchlists to add or remove NBP